BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16598346)

  • 1. Tamoxifen effects on treatment fibrocystic breast disease in women.
    Mousavi SR; Rezaei M
    Saudi Med J; 2006 Apr; 27(4):565-6. PubMed ID: 16598346
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic aspects of mammary dysplasia with antiestrogens].
    Baracat FF; Pontes MD; Rodrigues de Lima G
    Rev Paul Med; 1982; 100(3):28-9. PubMed ID: 7184117
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen responders selection by computerized contact thermography in benign breast disease.
    Cupceancu B; Mogoş I; Cotruţă C
    Endocrinologie; 1986; 24(2):115-22. PubMed ID: 3738400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mastodynia and fibrocystic disease of the breast].
    Pons JY
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):129. PubMed ID: 3584864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Update in the therapy of fibrocystic mastopathy].
    Zanoio L; Zacché G; Mainenti M; Silvestre V
    Minerva Ginecol; 1987 Dec; 39(12):833-8. PubMed ID: 3329703
    [No Abstract]   [Full Text] [Related]  

  • 6. Benign breast disease.
    Mauvais-Jarvis P; Kuttenn F
    Curr Ther Endocrinol Metab; 1994; 5():364-70. PubMed ID: 7704754
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemoprevention of breast cancer for women at high risk.
    Chan K; Morris GJ
    Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Breast dysplasia. Review of the drugs used in its treatment].
    Rodriguez De Lima G; Gebrin LH; Baracat F
    Rev Paul Med; 1986; 104(2):82-6. PubMed ID: 3544146
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of breast pain.
    Faiz O; Fentiman IS
    Int J Clin Pract; 2000 May; 54(4):228-32. PubMed ID: 10912311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ovarian hyperstimulation in women with fibrocystic mammary dysplasia treated with tamoxifen].
    Gallardo M; Vaccaro H
    Rev Chil Obstet Ginecol; 1993; 58(4):328-9. PubMed ID: 7991853
    [No Abstract]   [Full Text] [Related]  

  • 11. Tamoxifen and peripubertal women.
    Costello SA; Bassford C
    Australas Radiol; 1998 Nov; 42(4):397. PubMed ID: 9833388
    [No Abstract]   [Full Text] [Related]  

  • 12. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
    Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
    J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical management of mammary dysplasia.
    London RS; Sundaram GS; Goldstein PJ
    Obstet Gynecol; 1982 Apr; 59(4):519-23. PubMed ID: 7043344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal HRT--a role for tamoxifen?
    Jackson G
    Int J Clin Pract; 1997; 51(5):267. PubMed ID: 9489081
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of fibrocystic mastopathy by an antiestrogen, tamoxifen.
    Shaaban MM; Morad F; Hassan Ael R
    Int J Gynaecol Obstet; 1980; 18(5):348-50. PubMed ID: 6110580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
    Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
    Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrocystic disorders of the breast].
    Tserotas K; Morán Villota C
    Ginecol Obstet Mex; 1998 Sep; 66():362-6. PubMed ID: 9789408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of scleredema diabeticorum with tamoxifen.
    Alsaeedi SH; Lee P
    J Rheumatol; 2010 Dec; 37(12):2636-7. PubMed ID: 21123339
    [No Abstract]   [Full Text] [Related]  

  • 19. Ratio of 17HSD1 to 17HSD2 protein expression predicts the outcome of tamoxifen treatment in postmenopausal breast cancer patients.
    Jansson A; Delander L; Gunnarsson C; Fornander T; Skoog L; Nordenskjöld B; Stål O
    Clin Cancer Res; 2009 May; 15(10):3610-6. PubMed ID: 19401349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can tamoxifen relieve fibromyalgia?].
    Simonson N
    Lakartidningen; 1996 Jan; 93(5):340. PubMed ID: 8628058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.